General Info

Pernix Therapeutics is an integrated specialty pharmaceutical company with development and commercial capabilities focused primarily on the pediatric market. Since its foundation, the company has focused on the acquisition, development, marketing and distribution of pharmaceutical products that provide timely and cost effective market entry through various regulatory pathways. All of its products and strategies are focused on creating solid intellectual property to protect the investment and development of the company s products. Products provided by Pernix Therapeutics include Cedax, QuinZyme, ReZyst IM and Upper Respiratory products.